Merck & Co's experimental antiviral drug molnupiravir has not shown "significant efficacy" against moderate Covid-19, a source with the Drug Controller General of India said.

Aurobindo Pharma Ltd wants to discontinue a late-stage trial of molnupiravir in moderate Covid-19 patients, the regulator's expert committee said on Friday...